Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,651,648 papers from all fields of science
Search
Sign In
Create Free Account
BCLC Stage B Hepatocellular Carcinoma
Known as:
Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
Intermediate hepatocellular carcinoma. Patients may benefit from chemoembolization. (HPB (Oxford) 2005; 7(1):35-41)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
24 relations
Abdominal Pain
Aberrant DNA Methylation
BCLC Stage
Bile Ducts, Extrahepatic
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Optimal timing of radiotherapy for incomplete transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
H. Byun
,
Nalee Kim
,
J. Seong
2020
Corpus ID: 214170309
521Background: Numerous studies have reported on the efficacy of radiotherapy (RT) after incomplete transarterial…
Expand
2020
2020
The Therapeutic Benefits of Combined Sorafenib for Intermediate Stage Hepatocellular Carcinoma Unresponsive to Transarterial Chemoembolization in a Chinese population.
Shou-Wu Lee
,
C. Tung
,
Yen-Chun Peng
,
H. Lien
,
Chi-Sen Chang
Journal of Digestive Diseases
2020
Corpus ID: 219105839
AIM Transarterial chemoembolization (TACE) is the treatment modality to the intermediate stage, or BCLC stage B hepatocellular…
Expand
2020
2020
Mo1418 UP-TO-8 CRITERIA IS ASSOCIATED WITH COMPLETE RESPONSE TO TRANSARTERIAL CHEMOEMBOLIZATION FOR BCLC STAGE B HEPATOCELLULAR CARCINOMA
Y. Hung
,
Yi‐Hsiang Huang
,
M. Hou
,
Y. Chao
,
I‐Cheng Lee
2020
Corpus ID: 219511636
2018
2018
A novel scoring system to predict ascites development post hepatectomy for BCLC stage B hepatocellular carcinoma
Honggang Qian
,
Li-Ying Wu
,
+6 authors
C. Hao
2018
Corpus ID: 80516156
Background: To develop a novel scoring system to predict the development of post-operative ascites by analyzing…
Expand
2017
2017
Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis .
Y. Huang
,
Bin Chen
,
+4 authors
Jian-yong Yang
International journal of clinical pharmacology…
2017
Corpus ID: 40868328
OBJECTIVE Barcelona clinic liver cancer (BCLC) stage B hepatocellular carcinoma (HCC) is a heterogeneous disease group…
Expand
2017
2017
Microwave-assisted liver resection is safe and effective for selecting patients with BCLC stage B hepatocellular carcinoma
Zu-bing Chen
,
Wei Li
,
+6 authors
Zi Ye
2017
Corpus ID: 4974553
This study aimed to evaluate the feasibility and effectiveness of microwave ablation-assisted liver resection (MW-LR) and clamp…
Expand
2015
2015
Transcatheter Arterial Chemoembolization With Gelatin Sponge Microparticles Treated for BCLC Stage B Hepatocellular Carcinoma
As'adi Kamran
,
Y. Liu
,
Feng Li
,
Song Liu
,
J. Wu
,
Yue-wei Zhang
Medicine
2015
Corpus ID: 16217214
AbstractGelatin sponge particles are commonly used in the conventional transarterial chemoembolization (c-TACE) as an adjuvant…
Expand
2015
2015
Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma: a Letter to Response
Wei Liu
,
Jian-Guo Zhou
,
B. Xing
Journal of Gastrointestinal Surgery
2015
Corpus ID: 11727376
As a general principle, it is essential to generate, summarize, and understand the best available evidence in order to establish…
Expand
2015
2015
Cerebral Lipiodol embolism
Liver international (Print)
2015
Corpus ID: 206172674
This case focused on a 66-year-old woman, who was a hepatitis B carrier with Barcelona Clinic Liver Cancer stage B hepatocellular…
Expand
2012
2012
Analysis of prognostic factors in 169 patients with BCLC stage B hepatocellular carcinoma after hepatectomy
Wu Guo-bi
2012
Corpus ID: 76046837
Objective To investigate prognostic factors affecting the outcomes of patients with Barcelona Clinic Liver Cancer(BCLC) stage B…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE